Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays

Abstract Introduction We assessed the concordance of cerebrospinal fluid (CSF) amyloid beta (Aβ) and tau measured on the fully automated Lumipulse platform with pre‐symptomatic Alzheimer's disease (AD) pathology on amyloid positron emission tomography (PET). Methods In 72 individuals from the Insigh...

Description complète

Détails bibliographiques

Auteurs principaux:	Ashvini Keshavan, Henrietta Wellington, Zhongbo Chen, Ayesha Khatun, Miles Chapman, Melanie Hart, David M. Cash, William Coath, Thomas D. Parker, Sarah M. Buchanan, Sarah E. Keuss, Matthew J. Harris, Heidi Murray‐Smith, Amanda Heslegrave, Nick C. Fox, Henrik Zetterberg, Jonathan M. Schott
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2020-01-01
Collection:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Sujets:	amyloid CSF Lumipulse PET tau
Accès en ligne:	https://doi.org/10.1002/dad2.12097
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!